Order Article Reprints

Aripov VS, Zaykovskaya AV, Mechetina LV, Najakshin AM, Bondar AA, Arkhipov SG, Mustaev EA, Ilyina MG, Borisevich SS, Ilyichev AA, et al. The Use of Heterologous Antigens for Biopanning Enables the Selection of Broadly Neutralizing Nanobodies Against SARS-CoV-2. Antibodies. 2025; 14(1):23. https://doi.org/10.3390/antib14010023

Aripov, Vazirbek S., Anna V. Zaykovskaya, Ludmila V. Mechetina, Alexander M. Najakshin, Alexander A. Bondar, Sergey G. Arkhipov, Egor A. Mustaev, Margarita G. Ilyina, Sophia S. Borisevich, Alexander A. Ilyichev, and et al. 2025. "The Use of Heterologous Antigens for Biopanning Enables the Selection of Broadly Neutralizing Nanobodies Against SARS-CoV-2" Antibodies 14, no. 1: 23. https://doi.org/10.3390/antib14010023

Aripov, V. S., Zaykovskaya, A. V., Mechetina, L. V., Najakshin, A. M., Bondar, A. A., Arkhipov, S. G., Mustaev, E. A., Ilyina, M. G., Borisevich, S. S., Ilyichev, A. A., Nesmeyanova, V. S., Isaeva, A. A., Volosnikova, E. A., Shcherbakov, D. N., & Volkova, N. V. (2025). The Use of Heterologous Antigens for Biopanning Enables the Selection of Broadly Neutralizing Nanobodies Against SARS-CoV-2. Antibodies, 14(1), 23. https://doi.org/10.3390/antib14010023